Understanding Outcomes with the EMBLEM™ S-ICD in Primary Prevention Patients with Low Ejection Fraction Save

Date Added
September 20th, 2016
PRO Number
Pro00057463
Researcher
John Sturdivant
Keywords
Cardiovascular, Heart
Summary

The primary objective is to assess the 18-month incidence of inappropriate shocks in subjects implanted with the EMBLEM Subcutaneous Implantable Defibrillator (S-ICD) programmed with zone cutoffs at 200 bpm and 250 bpm. The UNTOUCHED study will test this programming scheme designed to minimize inappropriate and unnecessary shocks in patients who have an indication for primary prevention of sudden cardiac death and low ejection fraction. Subjects will be followed semi-annually according to standard of care for a minimum of 18 months post implant.

Institution
MUSC
Recruitment Contact
Deborah Everidge
843-792-2944
adamsde@musc.edu

Change_preferences

-- OR --

Create_login